Quotes aTyr Pharma, Inc. Deutsche Boerse AG
Equities
471A
US0021202025
Biotechnology & Medical Research
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.61 EUR | +10.27% | +2.10% | +13.18% |
05-02 | ATyr Pharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
05-02 | Earnings Flash (LIFE) ATYR PHARMA Reports Q1 Revenue $235,000 | MT |
Quotes 5-day view
Delayed Quote Deutsche Boerse AG29/04/2024 | 30/04/2024 | 02/05/2024 | 03/05/2024 | 06/05/2024 | |
---|---|---|---|---|---|
Last | 1.43 € | 1.46 € | 1.44 € | 1.46 € | 1.46 € |
Change | -1.38% | +2.10% | -1.37% | +1.39% | +10.27% |
Performance
1 day | +10.27% | ||
1 week | +2.10% | ||
1 month | -13.10% | ||
3 months | -5.19% | ||
6 months | +24.79% | ||
Current year | +13.18% | ||
1 year | -23.96% | ||
3 years | -53.50% | ||
5 years | -80.79% |
Volumes
marketsBasic data
Highs and lows
Indicators
Sector Comparison - Other Biotechnology & Medical Research
Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
---|---|---|---|---|---|---|
+10.27% | +2.10% | +13.18% | -23.96% | 109M | ||
-2.80% | +8.88% | +22.20% | -7.76% | 47.9B | ||
-0.23% | -0.77% | +46.56% | -10.34% | 41.42B | ||
+1.12% | -3.99% | -2.29% | +19.11% | 40.7B | ||
+0.80% | +7.02% | -6.20% | +15.95% | 28.92B | ||
+1.42% | +2.93% | +10.59% | +64.92% | 25.55B | ||
-0.94% | +2.51% | -21.08% | -28.05% | 19.27B | ||
-1.98% | +17.58% | -1.70% | -7.80% | 12.15B | ||
+2.64% | +0.95% | +31.81% | +92.83% | 12.14B | ||
+0.70% | +1.30% | -0.54% | +23.83% | 11.99B | ||
-0.93% | +9.24% | +18.36% | +23.66% | 11.64B | ||
-0.63% | +1.10% | -4.49% | -9.96% | 9.53B | ||
-2.86% | +5.36% | +36.33% | +59.98% | 6.85B | ||
-0.31% | +14.69% | +15.76% | +95.21% | 6.71B | ||
+0.68% | -0.37% | +24.46% | -22.06% | 6.66B | ||
+4.47% | +7.02% | +12.33% | -29.83% | 6.6B | ||
Average | +0.66% | +6.84% | +12.21% | +15.98% | ||
Weighted average by Cap. | -0.19% | +5.36% | +12.89% | +13.04% |
Historical data
Date | Opening | High | Low | End-of-day | Volume |
---|
Monthly variations
Annual change
2024 | +13.18% | ||
2023 | -32.67% | ||
2022 | -69.83% | ||
2021 | +95.99% | ||
2020 | -15.18% | ||
2019 | -35.03% | ||
2018 | -86.39% | ||
2017 | +47.35% | ||
2016 | -21.21% |
- Stock Market
- Equities
- LIFE Stock
- 471A Stock
- Quotes aTyr Pharma, Inc.